Blog

Coronavirus (COVID-19) Update: FDA Limits Use of Janssen COVID-19 Vaccine to Certain Individuals

 Today, the U.S. Food and Drug Administration has limited the authorized use of the Janssen COVID-19…

WallachBeth Capital Announces Pricing of ABVC BioPharma, Inc. (Nasdaq: ABVC) $4.22 Million Registered Direct Offering

WallachBeth Capital LLC, a leading provider of capital markets and institutional execution services, announced that ABVC…

Inmagene Receives FDA IND Clearance for a Third Generation BTK Inhibitor Targeting Immunological Diseases

 Inmagene Biopharmaceuticals (“Inmagene”) announces that today the U.S. Food and Drug Administration (FDA) cleared its investigational…

Freshly and ASICS Join Forces To Release Limited-Edition Meal Plans for Runners

 Freshly, the leading prepared meal delivery service in the U.S., and ASICS, a leading designer and manufacturer…

The Stepping Stones Group acquires HM Therapy

The Stepping Stones Group (Stepping Stones), a premier, national provider of therapeutic, behavioral, autism, nursing and…

Health and Nutrition Social Media Star Sarah Grace Meck, RD, Signs Long-term Deal with Thorne HealthTech

Sarah Grace, one of the most well-known health and nutrition influencers, who has more than 700,000…

Greenfire Bio to update progress on Phase 1 Clinical Trial for SIK2/SIK3 inhibitor, GRN-300, in ovarian cancer at the ASCO Annual Meeting 2022

 Greenfire Bio, LLC announced today that its subsidiary, Green3Bio, and its collaborators at MD Anderson Cancer…

NHS Management, LLC Provides Notice of Data Privacy Incident

 NHS Management, LLC (“NHS”) is providing notice of an event that may affect the security of…

WELL Health Reports Record Quarterly Revenue reflecting 395% Growth for Q1-2022 Accelerating Organic Growth and Increases Annual Guidance

WELL reported record quarterly revenues of $126.5 million in Q1-2022 representing a 395% year-over-year (YoY) increase compared to…

Antengene Announces Commercial Availability of XPOVIO® (Selinexor), for the Treatment of Relapsed/Refractory Multiple Myeloma, Prescribed for the First Time Across Mainland China

XPOVIO® will be available in 600 hospitals and 105 DTPs (across China including Beijing, Shanghai, Guangdong, Jiangsu, Zhejiang, Henan, and Shandong). SHANGHAI and HONG KONG, May 15, 2022 /PRNewswire/ — Antengene…